Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23473348 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Desvenlafaxine succinate sustained release 50 mg;   Drug: Desvenlafaxine succinate sustained release 25 mg;   Drug: Placebo

Indicates status has not been verified in more than two years